Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.

scientific article

Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/NEUP.12405
P698PubMed publication ID28856744

P50authorAnamarija M PerryQ88882568
P2093author name stringWeiwei Zhang
Marc R Del Bigio
Fausto Loberiza
Timothy C Greiner
Lynette M Smith
Mei Zheng
David Szwajcer
Philip Bierman
Michel R Nasr
P2860cites workThe somatic genomic landscape of glioblastomaQ28300185
Oncogenically active MYD88 mutations in human lymphomaQ28301648
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphomaQ33608166
Mutational analysis of primary central nervous system lymphomaQ34104139
B-cell receptor signaling in diffuse large B-cell lymphomaQ35218042
Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphomaQ36220001
Primary lymphoma of the central nervous system: just DLBCL or not?Q37273021
Targeting pathological B cell receptor signalling in lymphoid malignanciesQ38085501
Predictive biomarkers in adult gliomas: the present and the futureQ38146515
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomasQ39578940
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaQ40182586
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literatureQ41460237
High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sitesQ41960712
Current and emerging pharmacotherapies for primary CNS lymphomaQ42126754
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.Q42285217
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT statusQ43258495
CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patientsQ44378625
MGMT promoter methylation in plasma of glioma patients receiving temozolomideQ45088198
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphomaQ45183858
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.Q48109166
MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphomaQ48656685
Genomic characterization of primary central nervous system lymphomaQ49011918
CD79B and MYD88 mutations in diffuse large B-cell lymphomaQ51121788
Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.Q51329192
Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.Q54187253
O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment.Q54345375
P433issue6
P304page(s)509-516
P577publication date2017-08-30
P1433published inNeuropathologyQ15761930
P1476titleFrequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma
P478volume37

Reverse relations

cites work (P2860)
Q92283033Genetic alterations and their clinical implications in DLBCL
Q92253999MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
Q47118882Mutational profile of primary breast diffuse large B-cell lymphoma
Q47162060New developments in the pathology of malignant lymphoma. A review of the literature published from September-August 2017.
Q55712161Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.

Search more.